The Cincinnati Addiction Research Center (CinARC) proposes to form the Ohio Valley Node of the NIDA Clinical Trials Network (CTN) and to function as its Regional Research and Training Center (RRTC). The Ohio Valley Node would initially encompass the University of Cincinnati-based RRTC and six community-based treatment programs (CTPs) in Ohio, Indiana, Kentucky, and West Virginia. It would thus contribute a mid-western and Appalachian presence to the CTN, enhancing the network's geographical and cultural diversity. The goal of this proposal is to facilitate the CTN's evaluation and implementation of effective substance abuse treatments in community settings by operating a highly efficient and effective node that includes diverse treatment programs and patient populations. The Ohio Valley Node RRTC is primarily composed of the research team that has successfully conducted clinical trials for the Cincinnati NIDA Medication Development Research Unit (MDRU) since 1995. The RRTC team thus has extensive experience in conducting both single- and multi-site substance abuse trials in cooperation with NIDA and other NIDA-funded centers and has been recognized by NIDA for excellence in conducting clinical trials. The initial six CTPs of the Ohio Valley Node bring a rich variety of substance abuse services, treatment modalities, and patient populations to the CTN. Together, they treat almost 18,000 substance abuse patients per year from a population pool of 6.8 million persons. The CTPs have been highly involved in the development of this proposal and are committed to the goals of the CTN. The success of a CTN node is largely contingent upon establishing collaborative relationships among its RRTC and CTPs. The organizational and management plan of the Ohio Valley Node has been designed to enable the RRTC to provide the infrastructure, scientific leadership, and support functions necessary for successful operation while ensuring that the RRTC and CTPs are able to work collaboratively at a variety of levels. Parallel functional areas have been built into the RRTC, CTP, and node structures to facilitate communication between CTP and RRTC staff, to encourage the flow of experience-based insights from the CTPs to the RRTC, and to foster the transfer of technology from the RRTC to the CTPs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10DA013732-02
Application #
6379105
Study Section
Special Emphasis Panel (ZDA1-WXG-F (27))
Program Officer
Tai, Betty
Project Start
2000-09-30
Project End
2005-08-31
Budget Start
2001-09-10
Budget End
2002-08-31
Support Year
2
Fiscal Year
2001
Total Cost
$2,200,000
Indirect Cost
Name
University of Cincinnati
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Garrett, Sharon B; Doyle, Suzanne R; Peavy, K Michelle et al. (2018) Age differences in outcomes among patients in the ""Stimulant Abuser Groups to Engage in 12-Step"" (STAGE-12) intervention. J Subst Abuse Treat 84:21-29
Levran, Orna; Correa da Rosa, Joel; Randesi, Matthew et al. (2018) A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction. PLoS One 13:e0199951
Winhusen, Theresa; Feaster, Daniel J; Duan, Rui et al. (2018) Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav 22:2026-2032
Winhusen, Theresa; Lewis, Daniel (2017) Cigarette smoking in pregnant substance users: Association with substance use and desire to quit. J Addict Dis 36:88-91
Campbell, Aimee N C; Montgomery, L; Sanchez, Katherine et al. (2017) Racial/ethnic subgroup differences in outcomes and acceptability of an Internet-delivered intervention for substance use disorders. J Ethn Subst Abuse 16:460-478
Lee, J D; Tofighi, B; McDonald, R et al. (2017) Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults. Health Justice 5:3
Trivedi, Madhukar H; Greer, Tracy L; Rethorst, Chad D et al. (2017) Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study. J Clin Psychiatry 78:1075-1082
Lévesque, Annie; Campbell, Aimee N C; Pavlicova, Martina et al. (2017) Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addict Behav 65:74-80
Korthuis, Philip T; Lum, Paula J; Vergara-Rodriguez, Pamela et al. (2017) Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial. Addiction 112:1036-1044
Pan, Yue; Liu, Hongmei; Metsch, Lisa R et al. (2017) Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach. AIDS Behav 21:534-546

Showing the most recent 10 out of 133 publications